Fetal surgery for spina bifida: what it is and how it works
Fetal surgery for spina bifida is a specialised prenatal intervention performed to close open neural tube defects, most commonly myelomeningocele, while the developing foetus remains inside the womb. During normal gestation, the neural tube closes within the fourth week following conception. In open spina bifida, the overlying spinal column fails to fuse, leaving the delicate spinal cord and nerve roots exposed to the uterine environment. Surgeons understand this damage through the "two-hit hypothesis": the first hit is the congenital failure of the tube to close, and the second hit is progressive chemical and physical trauma from ongoing exposure to amniotic fluid and contact with the uterine wall. Closing the lesion in utero shields vulnerable neural tissue before irreversible damage occurs. For broader paediatric services, see our guide to paediatrics treatments in Turkey.
Intervening before birth fundamentally alters the condition's progression. By sealing the exposed neural placode, surgery stops cerebrospinal fluid leakage from the spine. This restores fluid pressure within the brain and prompts herniated cerebellar tissue to shift back into the skull, reversing Chiari II malformation. While prenatal repair cannot rebuild missing nerves or reverse structural defects established early in embryonic life, it preserves motor tracts and reduces central nervous system complications. Expectant parents researching fetal surgery for spina bifida in Turkey require clear guidance on surgical methods, clinical evidence, recovery, and hospital selection.
How in-utero spina bifida repair works step by step
Prenatal myelomeningocele repair is an intricate procedure performed between 19 and 25.9 weeks of gestation. It requires coordinated care between maternal-fetal medicine specialists, paediatric neurosurgeons, and obstetric anaesthetists. Under maternal general anaesthesia, deep uterine relaxation is maintained with tocolytic drugs to prevent premature contractions.
The operation follows five coordinated stages:
- Uterine exposure: In open surgery, a low transverse maternal laparotomy exposes the uterus. Ultrasound confirms placental boundaries and fetal position, allowing a small hysterotomy incision safely away from the placenta to expose the fetal back. Fetoscopic techniques instead use small ports and an endoscope under continuous ultrasound visualization.
- Neural placode dissection: Under high surgical magnification, the neurosurgeon separates the delicate neural placode from the surrounding epithelial border, gently freeing tethered nerve roots.
- Dural canal closure: The placode is tubularised into the spinal canal. The dura mater is mobilised and sutured closed across the midline to establish a watertight seal against spinal fluid leaks, occasionally reinforced with a dural graft.
- Myofascial and skin coverage: Paraspinal myofascial tissue is advanced over the dural repair, followed by layered skin closure. Relaxing lateral incisions or biomaterial patches are used if the skin defect is broad.
- Amniotic replacement and uterine seal: Warm sterile Ringer's lactate with antibiotics is infused into the amniotic space. The hysterotomy is closed with multiple watertight suture layers and biological sealant before abdominal wall closure.
Does fetal surgery for spina bifida work: clinical trial evidence
The clinical efficacy of prenatal repair is validated by robust medical evidence, primarily the landmark Management of Myelomeningocele Study (MOMS). This randomized controlled trial compared prenatal repair before 26 weeks with standard postnatal closure within 48 hours of birth, showing clear advantages for in-utero intervention.
The primary finding of the MOMS trial was a 50 percent reduction in the need for ventriculoperitoneal shunts or endoscopic third ventriculostomies to treat hydrocephalus by 12 months of age. In addition, in-utero repair led to significant reversal or resolution of Chiari II hindbrain herniation, where the hindbrain descends into the upper spinal canal. Prenatal closure also doubled the proportion of children capable of independent walking at 30 months compared with those undergoing postnatal surgery.
However, clinical evidence also highlights clear boundaries. Fetal surgery is not a cure. The trial demonstrated that prenatal intervention does not resolve neurogenic bladder or bowel dysfunction; nearly all children still require clean intermittent catheterisation and paediatric urological care. Furthermore, children with higher thoracic lesions may still require wheelchairs or walking aids. Expectant parents must weigh these functional gains against potential maternal and obstetric risks.
Fetal surgery for spina bifida cost in Turkey compared with the UK, US, and Germany
The total fetal surgery for spina bifida cost reflects the extensive surgical and neonatal resources needed for dual-patient care. Costs cover maternal-fetal subspecialists, paediatric neurosurgeons, specialised anaesthesia, maternal high-dependency care, and subsequent neonatal monitoring. The figures below outline approximate international hospital ranges.
| Country | Approximate cost range |
|---|---|
| Turkey | €20,000 – €45,000 |
| United Kingdom | €40,000 – €90,000 |
| United States | €85,000 – €220,000 |
| Germany | €45,000 – €110,000 |
Several clinical variables affect the fetal surgery for spina bifida price. Key factors include whether open hysterotomy or fetoscopic surgery is chosen, the duration of required inpatient maternal observation, tocolytic medication protocols, and neonatal intensive care unit (NICU) requirements after delivery. Packages in Turkey typically include preoperative fetal MRI and echocardiography, the surgical operation, maternal hospital accommodation, routine medications, and obstetric follow-up up to delivery. Request a tailored review through our free quote service.
Comparing surgical techniques: open hysterotomy, fetoscopic repair, and postnatal closure
Expectant parents comparing spina bifid surgery options should understand the three primary surgical approaches and their physiological trade-offs.
| Method | Best suited to | Typical limits |
|---|---|---|
| Open hysterotomy fetal repair | Singleton pregnancies at 19–25.9 weeks with Chiari II and normal karyotype | Requires maternal laparotomy; leaves permanent uterine scar requiring future Caesarean deliveries |
| Fetoscopic prenatal repair | Selected mid-gestation candidates meeting anatomical criteria for port access | Technically demanding; longer operative duration; variable rates of chorioamniotic membrane separation |
| Postnatal direct microsurgical closure | Infants diagnosed late in pregnancy or born with lesions unsuitable for in-utero intervention | Does not reverse hindbrain herniation; higher lifetime rate of hydrocephalus shunt dependence |
Open hysterotomy is the most rigorously studied technique, providing direct surgical access and reliable watertight dural sealing. However, it imposes maternal physical stress, uterine wall thinning, and requires Caesarean delivery for all subsequent pregnancies. Fetoscopic repair uses miniature instruments and camera ports, avoiding a major uterine incision and preserving the uterine wall, but it requires specialised endosurgical skill and carries membrane detachment risks. Postnatal repair within 48 hours of birth entails no surgical risks for the mother, but forfeits the neurological protection gained by shielding the spinal cord in utero.
Maternal and fetal eligibility criteria for prenatal surgery
Because in-utero intervention carries maternal and fetal hazards, candidate selection follows strict criteria defined by international fetal therapy consortia. Candidates undergo comprehensive screening, including high-resolution neurosonography, ultrafast fetal MRI, echocardiography, and chromosomal microarray testing.
Fetal eligibility requirements include:
- Gestational age strictly between 19 weeks 0 days and 25 weeks 6 days at the time of surgery.
- Upper anatomical boundary of the myelomeningocele lesion located between T1 and S1.
- Confirmed Chiari II malformation with downward herniation of the hindbrain.
- Normal fetal karyotype or chromosomal microarray, excluding major trisomies.
- No severe structural anomalies, congenital heart defects, or severe spinal kyphosis exceeding 30 degrees.
Maternal criteria require a singleton pregnancy and no prior classical uterine incisions. Mothers must be in good general health, without medical contraindications to major surgery such as severe cardiac disease, uncontrolled hypertension, or severe obesity. Cervical length must be adequate, with no evidence of placenta praevia or elevated preterm labour risk.
Fetal surgery for spina bifida recovery and maternal hospital care
Postoperative care prioritises maternal stability and the prevention of preterm labour. Immediately after surgery, the mother is monitored in a high-dependency unit with continuous tocolytic therapy, such as magnesium sulphate and progesterone, to suppress uterine contractions. Maternal fluid intake is strictly regulated to guard against pulmonary oedema. Daily Doppler ultrasound scans check fetal wellbeing, heart rates, and amniotic fluid volume.
The inpatient stay in Turkey is generally 5 to 10 days if maternal recovery is uncomplicated and uterine activity remains quiet. After discharge, the mother stays nearby for regular outpatient surveillance, including weekly ultrasound checks of cervical length and fetal development. Daily physical activity is restricted to bed rest and light walking. Delivery is arranged by scheduled Caesarean section at around 37 weeks of gestation, or earlier if spontaneous labour occurs. Learn about hospital admissions and travel logistics by reading how it works.
Realistic outcomes and long-term child development
Families researching fetal surgery for spina bifida Turkey must maintain realistic expectations. In-utero repair is not a cure that restores a child's spinal cord to normal anatomy. Instead, its purpose is to arrest secondary damage. Successful operations frequently lead to substantial improvement on follow-up ultrasound scans, with the hindbrain shifting back upward into the posterior cranial fossa before birth.
Long-term mobility depends on the anatomical level of the lesion. Children treated prenatally are significantly more likely to walk independently or with orthoses compared to those treated postnatally, often functioning at higher motor levels than their anatomical defect would suggest. However, neurogenic bladder and bowel dysfunction persist in the vast majority of cases. Lifelong paediatric urological supervision, clean intermittent catheterisation, and periodic renal ultrasounds remain essential. Structured physical therapy and development programmes link with broader paediatrics treatments in Turkey to support mobility and independent development.
Maternal and fetal risks of in-utero spina bifida repair
Prenatal surgery involves substantial clinical risks for both mother and child. Major medical bodies, including the NHS and the American College of Obstetricians and Gynecologists (ACOG), highlight that the mother undergoes a major operation solely for fetal benefit, accepting surgical hazards without direct physical gain to herself.
Primary clinical complications include:
- Preterm premature rupture of membranes (PPROM): Membrane separation or rupture occurs in approximately 30 to 45 percent of cases, increasing the risk of oligohydramnios and chorioamnionitis.
- Preterm delivery: Most treated fetuses deliver prematurely, with an average delivery gestational age around 34 weeks, requiring neonatal intensive care for respiratory support and feeding development.
- Uterine thinning and dehiscence: The hysterotomy site may thin as the uterus expands, carrying a 1 to 2 percent risk of uterine rupture that demands emergency delivery.
- Maternal complications: Heavy tocolytic administration carries risks of pulmonary oedema, maternal anaemia requiring transfusion, and wound infection.
- Fetal mortality: Procedure-related fetal demise or neonatal death occurs in approximately 2 to 3 percent of cases, primarily associated with severe prematurity.
How to choose a fetal surgery centre and essential questions to ask
Fetal surgery should only be undertaken in accredited university teaching hospitals with established maternal-fetal surgery programmes. A qualified facility must house maternal-fetal medicine subspecialists, paediatric neurosurgeons, obstetric anaesthetists, and an on-site Level IV neonatal intensive care unit under one roof. Families can consult how it works to understand medical records review and international coordination.
Red flags include clinics that offer fetal intervention after 26 weeks, centres without on-site advanced neonatal intensive care, or any team that promises a cure for paralysis or bladder impairment. Before proceeding, parents should ask the surgical team:
- How many prenatal spina bifida repairs has your multidisciplinary team performed?
- What are your centre's specific rates of PPROM, preterm birth, and maternal uterine dehiscence?
- Is an advanced Level IV neonatal intensive care unit located directly within the facility?
- What post-surgical tocolytic and maternal monitoring protocols do you employ?
- How is maternal and fetal surveillance managed between hospital discharge and delivery?
- What paediatric urology, orthopaedic, and physical rehabilitation support is organised after birth?
To request a confidential clinical review of your scans and medical history, submit an enquiry for a free quote.
Conditions treated with Fetal Surgery for Spina Bifida
Hospitals with Paediatrics in Turkey
Frequently asked questions
Fetal surgery for spina bifida is a specialised prenatal operation performed between 19 and 25.9 weeks of pregnancy to repair myelomeningocele in the womb. The surgical team closes the exposed neural placode, dura mater, and overlying skin to protect the spinal cord from continuous exposure to amniotic fluid and prevent further neurological damage.
Clinical evidence from the landmark MOMS trial confirms that fetal surgery reduces the need for hydrocephalus shunts by 50 percent, reverses Chiari II hindbrain herniation, and doubles the likelihood of independent walking at 30 months compared with postnatal surgery. However, it does not cure the condition or eliminate lifelong neurogenic bladder and bowel dysfunction.
Approximate costs in Turkey range from €20,000 to €45,000, compared with €40,000 to €90,000 in the UK and €85,000 to €220,000 in the US. The price covers maternal-fetal medicine subspecialists, paediatric neurosurgery, operating theatre fees, tocolytic monitoring, and initial maternal hospitalisation. Individual hospital quotes depend on surgical technique and post-delivery neonatal requirements.
Fetal surgery seals the physical defect and halts ongoing toxic damage, allowing the hindbrain to migrate back into position. It improves motor potential, but it does not reverse established embryonic nerve loss. Most children still need lifelong paediatric urology care, intermittent catheterisation, and ongoing physical therapy to support mobility and renal health.
Fetal surgery shields the developing spinal cord during mid-gestation, substantially lowering hydrocephalus shunt rates and improving walking outcomes, but it introduces maternal surgical risks and preterm birth. Postnatal closure carries zero surgical hazard for the mother, but fails to prevent in-utero neurological degradation or reverse Chiari II malformation.
Primary complications include preterm premature rupture of membranes (PPROM in 30 to 45 percent of cases), premature delivery around 34 weeks, and maternal uterine thinning or dehiscence. Intensive tocolytic therapy can occasionally cause maternal pulmonary oedema. Fetal mortality from surgery or extreme prematurity is approximately 2 to 3 percent.
Mothers typically remain hospitalised for 5 to 10 days for intensive tocolytic therapy and daily fetal monitoring. Following hospital discharge, bed rest and reduced physical activity continue until delivery, with weekly ultrasound examinations. Delivery is carried out by planned Caesarean section at around 37 weeks of gestation, or sooner if labour begins.
The mother is placed under deep general anaesthesia and receives postoperative intravenous and epidural analgesics, feeling no pain during surgery. The foetus receives anaesthetic agents across the placenta alongside direct fetal analgesia and neuromuscular blockade, ensuring complete pain control and immobility throughout the delicate spinal repair.
Candidates must be between 19.0 and 25.9 weeks of gestation with a singleton pregnancy, a confirmed myelomeningocele between T1 and S1, Chiari II malformation, and a normal chromosomal profile. Mothers must be free from major medical contraindications, severe obesity, and prior classical uterine incisions, with adequate cervical length and normal placental location.
Expectant mothers generally need an extended stay of four to eight weeks, or remain until delivery, depending on gestational age and stability. The initial stay covers preoperative fetal imaging, surgery, and 5 to 10 days of hospitalisation, followed by local outpatient monitoring until the obstetric team clears travel or planned delivery occurs.